Bone Therapeutics Overview

  • Founded
  • 2006
Founded
  • Status
  • Public
  • Employees
  • 58
Employees
  • Stock Symbol
  • BOTHE
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $2.94
  • (As of Monday Closing)

Bone Therapeutics General Information

Description

Bone Therapeutics SA is engaged in the development of cell therapy products for orthopaedics and bone diseases. The product pipeline of the company includes; ALLOB for treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion, and PREOB. In addition, the firm is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
BRU
Primary Office
  • Rue Auguste Piccard, 37
  • 6041 Gosselies
  • Belgium
+32 071 00 00 00

Bone Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bone Therapeutics Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.94 $2.98 $2.15 - $4.34 $48.5M 16.5M 26.1K -$1.47

Bone Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 38,091 46,806 47,700 62,563
Revenue 0 0 1,180 46
EBITDA (14,086) (10,125) (15,425) (13,445)
Net Income (16,318) (11,711) (16,778) (14,381)
Total Assets 25,467 25,084 29,459 30,200
Total Debt 24,665 15,362 14,701 14,159
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bone Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bone Therapeutics‘s full profile, request access.

Request a free trial

Bone Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Bone Therapeutics SA is engaged in the development of cell therapy products for orthopaedics and bone diseases. The prod
Biotechnology
Gosselies, Belgium
58 As of 2019
00000
000000000 00000

00000000

adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mini
0000000000000
Gaithersburg, MD
00 As of 0000
00000
0000 0000-00-00
00000000 00000

000000

dunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco la
0000 000000000
Seattle, WA
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bone Therapeutics Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
000000 Venture Capital-Backed Seattle, WA 00 000.00 0000000000 0 000.00
0000000 Venture Capital-Backed Diepenbeek, Belgium 0 000.00 00000000000 000.00
000000 Formerly VC-backed San Diego, CA 000 00000 000000 - 000 00000
0000000000 Corporate Backed or Acquired Basel, Switzerland 000000&0
You’re viewing 5 of 5 competitors. Get the full list »

Bone Therapeutics Executive Team (18)

Name Title Board Seat Contact Info
Miguel Forte Ph.D Chief Executive Officer
Jean-Luc Vandebroek Chief Financial Officer
Anthony Ting Ph.D Chief Scientific Officer
Guy Heynen MD Consultant
Stefanos Theoharis Ph.D Chief Business Officer
You’re viewing 5 of 18 executive team members. Get the full list »

Bone Therapeutics Board Members (21)

Name Representing Role Since
Claudia D'Augusta Ph.D Self Board Member 000 0000
Damian Marron Self Board Member 000 0000
Gloria Matthews Ph.D Self Board Member 000 0000
Jean Stéphenne Self Chairman 000 0000
Jean-Paul Prieels Ph.D Self Board Member 000 0000
You’re viewing 5 of 21 board members. Get the full list »

Bone Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bone Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bone Therapeutics‘s full profile, request access.

Request a free trial

Bone Therapeutics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000é0é 0'00000000 00000 00000 00 00000 Construction and Engineering
To view Bone Therapeutics’s complete investments history, request access »

Bone Therapeutics Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000é0é 0'00000000 00000 00000 00 00000 Completed
  • 3 buyers
To view Bone Therapeutics’s complete exits history, request access »